MedPath

Physical Activity as Adjunct Treatment for Opioid Substitution Therapy

Not Applicable
Suspended
Conditions
Substance Use Disorders
Opioid-use Disorder
Opioid Dependence
Interventions
Behavioral: Exercise
Registration Number
NCT04496934
Lead Sponsor
Haukeland University Hospital
Brief Summary

In terms of research, it is documented that exercise has a positive effect on mental disorders. Studies have shown positive correlations between physical and mental health, also among substance users. Such a study has never been performed on patients in opioid substitution therapy (OST). Documentation on the physical health of patients and the effect of exercise is very limited. Treatment of substance users is a research area with insufficient knowledge about certain treatment effects. It is important that a treatment can both support and promote the user's own resources and efforts to change their habits of substance use.

The objective of this project is to examine the effect of exercise for OST patients, measured in relation to cognitive function and physical form. The target group consists of OST patients from 18 years of age and up, of both sexes, and on stable medication. At least 60 participants should complete the project, which is designed as a controlled randomized study (RCT). Participants in the intervention group start to exercise immediately after baseline testing. Participants in the control group are on a waiting list and will start to exercise after twelve weeks. Both groups undergo testing at baseline, after three, six and 12 months. Testing consists of two parts: A battery of cognitive and psychosocial assessments and an assessment of physical variables.

The research questions of this project are important in a public health perspective. Generated knowledge can be quickly applied to local treatment institutions in Norway.

Detailed Description

Not available

Recruitment & Eligibility

Status
SUSPENDED
Sex
All
Target Recruitment
17
Inclusion Criteria
  • Participants must sign a informed consent form
  • Must be participating in an opioid substitution program
  • Must be on a steady fixed dose of medication
  • Must be at least 18 years of age
Exclusion Criteria
  • Pregnancy
  • Being in opioid substitution program for less than three months

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
InterventionExerciseExercise intervention
ControlExerciseThe control group is a waiting list group. The participants will receive exercise intervention after twelve weeks of treatment as usual.
Primary Outcome Measures
NameTimeMethod
Height and weight12 weeks

Weight and height will be combined to report BMI in kg/m\^2

Endurance12 weeks

Ventilatory threshold/VO2max (endurance test on treadmill)

Strength12 weeks

Push-ups (maximal test where the participants perform a maximum number of correct push-ups)

Balance12 weeks

Stork Balance Test (timed test where the goal is to keep one's balance as long as possible)

Secondary Outcome Measures
NameTimeMethod
Drug use12 weeks

DUDIT-E

Executive functions12 weeks

Behavior Rating Inventory of Executive Function - Adult Version (BRIEF-A)

Satisfaction with life12 weeks

Satisfaction With Life Scale (SWLS)

Values/scores:

* 7 - Strongly agree

* 6 - Agree

* 5 - Slightly agree

* 4 - Neither agree nor disagree

* 3 - Slightly disagree

* 2 - Disagree

* 1 - Strongly disagree

Results (sum of scores/values):

31 - 35 Extremely satisfied 26 - 30 Satisfied 21 - 25 Slightly satisfied 20 Neutral 15 - 19 Slightly dissatisfied 10 - 14 Dissatisfied 5 - 9 Extremely dissatisfied The higher the score the better the outcome.

Sleep quality12 weeks

Pittsburgh Sleep Quality Index (PSQI)

Attention12 weeks

Connors Continuous Performance Test (CPT 3)

Alcohol use12 weeks

AUDIT-E

Trial Locations

Locations (1)

Haukeland University Hospital

🇳🇴

Bergen, Norway

© Copyright 2025. All Rights Reserved by MedPath